Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor-Unfractionated Heparin Complex Inhibits Early Graft Thrombosis
Background: Bypass graft surgery remains to be an important treatment option for left main and multivessel coronary artery disease. Approximately 2% of saphenous vein grafts are lost immediately after the coronary artery bypass graft operations and 12% in the first month due to thrombosis. Aims: To...
Main Authors: | Ercan Akşit, Tolga Kurt, Başak Büyük, Ömer Çokkalender |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2020-09-01
|
Series: | Balkan Medical Journal |
Subjects: | |
Online Access: | http://www.balkanmedicaljournal.org/text.php?lang=en&id=2212 |
Similar Items
-
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding
by: Paolo Nardi, et al.
Published: (2020-01-01) -
Promoting vascular healing using nanofibrous ticagrelor-eluting stents
by: Lee CH, et al.
Published: (2018-10-01) -
Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts
by: Yuichi Matsuzaki, et al.
Published: (2021-05-01) -
Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin
by: Wesley E. Workman, et al.
Published: (2020-01-01) -
Comparison of Pregnancy Outcomes of Low Molecular Weight Heparin with Unfractionated Heparin in the Treatment of Recurrent Abortion Secondary to Antiphospholipid Syndrome
by: M Janghorbani, et al.
Published: (2013-09-01)